$50.00
-0.02-0.04%
Ult. Agg.: Oct 23, 7:20 PM
Eton Pharmaceuticals (ETON) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Eton Pharmaceuticals (ETON) ha pubblicato l'ultima guidance il agosto 13, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a per il periodo.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.18 | $0.13 | $0.17 | $0.15 |
| Actual | $0.43 | $0.14 | $0.19 | $0.04 |
| Surprise | +138.9% | +7.69% | +11.8% | -73.3% |
| Revenue | ||||
| Estimate | $27.1M | $22.4M | $20.5M | $20.5M |
| Actual | $37.6M | $24.3M | $21.3M | $22.5M |
| Surprise | +38.4% | +8.36% | +3.73% | +9.51% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.36 | $0.42 | $0.44 | $0.35 |
| Revenue | ||||
| Consensus | $42.2M | $46.1M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $0.43 | $0.18 | 138.9 % |
| Q1 | May 14, 2026 | $0.14 | $0.13 | 7.69 % |
| Q4 | Mar 19, 2026 | $0.19 | $0.17 | 11.8 % |
| Q3 | Nov 6, 2025 | $0.04 | $0.15 | -73.3 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $37.57M | $27.14M | 38.4 % |
| Q1 | May 14, 2026 | $24.27M | $22.39M | 8.36 % |
| Q4 | Mar 19, 2026 | $21.28M | $20.52M | 3.73 % |
| Q3 | Nov 6, 2025 | $22.46M | $20.51M | 9.51 % |